{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T03:09:09Z","timestamp":1787972949490,"version":"build-2784847793"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.metabol.2019.05.009","type":"journal-article","created":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T20:58:52Z","timestamp":1558731532000},"page":"68-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["The combination of exercise training and sodium-glucose cotransporter-2 inhibition improves glucose tolerance and exercise capacity in a rodent model of type 2 diabetes"],"prefix":"10.1016","volume":"97","author":[{"given":"Melissa A.","family":"Linden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trenton T.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Beebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew F.","family":"Gorgoglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karyn L.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin F.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William P.","family":"Esler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2019.05.009_bb0005","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1249\/MSS.0b013e31827ad8b4","article-title":"Exercise and 24-h glycemic control: equal effects for all type 2 diabetes patients?","volume":"45","author":"Van Dijk","year":"2013","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.metabol.2019.05.009_bb0010","doi-asserted-by":"crossref","first-page":"E151","DOI":"10.1152\/ajpendo.00210.2009","article-title":"Effects of 7 days of exercise training on insulin sensitivity and responsiveness in type 2 diabetes mellitus","volume":"297","author":"Kirwan","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2019.05.009_bb0015","doi-asserted-by":"crossref","first-page":"E607","DOI":"10.1152\/ajpendo.00729.2007","article-title":"Insulin-resistant muscle is exercise resistant: evidence for reduced response of nuclear-encoded mitochondrial genes to exercise","volume":"294","author":"De Filippis","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2019.05.009_bb0020","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1249\/00005768-199505000-00007","article-title":"Effects of non-insulin-dependent diabetes on oxygen consumption during treadmill exercise","volume":"27","author":"Regensteiner","year":"1995","journal-title":"Med Sci Sports Exerc"},{"issue":"Pt 3","key":"10.1016\/j.metabol.2019.05.009_bb0025","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1042\/bj3480607","article-title":"Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain","volume":"348","author":"Owen","year":"2000","journal-title":"Biochem J"},{"key":"10.1016\/j.metabol.2019.05.009_bb0030","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/716404","article-title":"The role of metformin in the management of NAFLD","volume":"2012","author":"Mazza","year":"2012","journal-title":"Exp Diabetes Res"},{"key":"10.1016\/j.metabol.2019.05.009_bb0035","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/oby.20235","article-title":"Metformin modifies the exercise training effects on risk factors for cardiovascular disease in impaired glucose tolerant adults","volume":"21","author":"Malin","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.metabol.2019.05.009_bb0040","doi-asserted-by":"crossref","first-page":"E300","DOI":"10.1152\/ajpendo.00427.2013","article-title":"Combining metformin and aerobic exercise training in the treatment of type 2 diabetes and NAFLD in OLETF rats","volume":"306","author":"Linden","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2019.05.009_bb0045","doi-asserted-by":"crossref","first-page":"E815","DOI":"10.1152\/ajpendo.00517.2009","article-title":"Combining short-term metformin treatment and one bout of exercise does not increase insulin action in insulin-resistant individuals","volume":"298","author":"Sharoff","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2019.05.009_bb0050","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1139\/apnm-2012-0433","article-title":"Effect of metformin on substrate utilization after exercise training in adults with impaired glucose tolerance","volume":"38","author":"Malin","year":"2013","journal-title":"Appl Physiol Nutr Metab"},{"key":"10.1016\/j.metabol.2019.05.009_bb0055","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s12020-009-9196-9","article-title":"Metformin in combination with structured lifestyle intervention improved body mass index in obese adolescents, but did not improve insulin resistance","volume":"36","author":"Clarson","year":"2009","journal-title":"Endocrine."},{"key":"10.1016\/j.metabol.2019.05.009_bb0060","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.2337\/dc10-2207","article-title":"Metformin and exercise in type 2 diabetes: examining treatment modality interactions","volume":"34","author":"Boule","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2019.05.009_bb0065","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1007\/s00125-013-3026-6","article-title":"Does metformin modify the effect on glycaemic control of aerobic exercise, resistance exercise or both?","volume":"56","author":"Boule","year":"2013","journal-title":"Diabetologia."},{"key":"10.1016\/j.metabol.2019.05.009_bb0070","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1139\/H07-144","article-title":"Impact of metformin on peak aerobic capacity","volume":"33","author":"Braun","year":"2008","journal-title":"Appl Physiol Nutr Metab"},{"key":"10.1016\/j.metabol.2019.05.009_bb0075","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12880","article-title":"Metformin inhibits mitochondrial adaptations to aerobic exercise training in older adults","volume":"18","author":"Konopka","year":"2019","journal-title":"Aging Cell"},{"key":"10.1016\/j.metabol.2019.05.009_bb0080","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1463-1326.2011.01406.x","article-title":"Canagliflozin, a novel inhibitor of sodium glucose co-transporter 2, dose dependently reduces calculated renal threshold for glucose excretion and increases urinary glucose excretion in healthy subjects","volume":"13","author":"Sha","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.metabol.2019.05.009_bb0085","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s00125-015-3547-2","article-title":"Effects of canagliflozin on body weight and relationship to HbA1c and blood pressure changes in patients with type 2 diabetes","volume":"58","author":"Cefalu","year":"2015","journal-title":"Diabetologia."},{"key":"10.1016\/j.metabol.2019.05.009_bb0090","doi-asserted-by":"crossref","first-page":"605","DOI":"10.14740\/jocmr3046w","article-title":"Effects of six kinds of sodium-glucose cotransporter 2 inhibitors on metabolic parameters, and summarized effect and its correlations with baseline data","volume":"9","author":"Yanai","year":"2017","journal-title":"J Clin Med Res"},{"key":"10.1016\/j.metabol.2019.05.009_bb0095","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.2337\/db15-1356","article-title":"Shift to fatty substrate utilization in response to sodium-glucose cotransporter 2 inhibition in subjects without diabetes and patients with type 2 diabetes","volume":"65","author":"Ferrannini","year":"2016","journal-title":"Diabetes."},{"key":"10.1016\/j.metabol.2019.05.009_bb0100","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejphar.2014.01.040","article-title":"SGLT2 selective inhibitor ipragliflozin reduces body fat mass by increasing fatty acid oxidation in high-fat diet-induced obese rats","volume":"727","author":"Yokono","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.metabol.2019.05.009_bb0105","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2019.05.009_bb0110","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12933-016-0489-z","article-title":"Sodium glucose transporter 2 (SGLT2) inhibition with empagliflozin improves cardiac diastolic function in a female rodent model of diabetes","volume":"16","author":"Habibi","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.metabol.2019.05.009_bb0115","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12933-017-0510-1","article-title":"A randomised study of the impact of the SGLT2 inhibitor dapagliflozin on microvascular and macrovascular circulation","volume":"16","author":"Ott","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.metabol.2019.05.009_bb0120","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.phrs.2005.05.004","article-title":"Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening","volume":"52","author":"Srinivasan","year":"2005","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.metabol.2019.05.009_bb0125","article-title":"The characterization of high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model","volume":"2008","author":"Zhang","year":"2008","journal-title":"Exp Diabetes Res"},{"key":"10.1016\/j.metabol.2019.05.009_bb0130","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00592-008-0038-7","article-title":"Effect of early insulin therapy on nuclear factor kappaB and cytokine gene expressions in the liver and skeletal muscle of high-fat diet, streptozotocin-treated diabetic rats","volume":"45","author":"Bi","year":"2008","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.metabol.2019.05.009_bb0135","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jdiacomp.2008.02.003","article-title":"Westernized-like-diet-fed rats: effect on glucose homeostasis, lipid profile, and adipocyte hormones and their modulation by rosiglitazone and glimepiride","volume":"23","author":"Schaalan","year":"2009","journal-title":"J Diabetes Complicat"},{"key":"10.1016\/j.metabol.2019.05.009_bb0140","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/1475-2840-12-136","article-title":"Cardiac metabolism in a new rat model of type 2 diabetes using high-fat diet with low dose streptozotocin","volume":"12","author":"Mansor","year":"2013","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.metabol.2019.05.009_bb0145","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1055\/s-0042-110934","article-title":"Streptozotocin-treated high fat fed mice: a new type 2 diabetes model used to study canagliflozin-induced alterations in lipids and lipoproteins","volume":"49","author":"Yu","year":"2017","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.metabol.2019.05.009_bb0150","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1139\/cjpp-2012-0294","article-title":"Exercise training prevents the development of cardiac dysfunction in the low-dose streptozotocin diabetic rats fed a high-fat diet","volume":"91","author":"Epp","year":"2013","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.metabol.2019.05.009_bb0155","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1152\/physiolgenomics.00078.2015","article-title":"AMPK agonist AICAR delays the initial decline in lifetime-apex Vo2 peak, while voluntary wheel running fails to delay its initial decline in female rats","volume":"48","author":"Toedebusch","year":"2016","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.metabol.2019.05.009_bb0160","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1152\/jappl.1998.84.1.164","article-title":"Increasing maximal heart rate increases maximal O2 uptake in rats acclimatized to simulated altitude","volume":"84","author":"Gonzalez","year":"1998","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.metabol.2019.05.009_bb0165","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1152\/japplphysiol.91566.2008","article-title":"Reproducibility of endurance capacity and VO2peak in male Sprague-Dawley rats","volume":"106","author":"Copp","year":"2009","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.metabol.2019.05.009_bb0170","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2337\/diabetes.51.3.567","article-title":"Effect of AICAR treatment on glycogen metabolism in skeletal muscle","volume":"51","author":"Aschenbach","year":"2002","journal-title":"Diabetes."},{"key":"10.1016\/j.metabol.2019.05.009_bb0175","doi-asserted-by":"crossref","first-page":"G619","DOI":"10.1152\/ajpgi.00428.2007","article-title":"Daily exercise increases hepatic fatty acid oxidation and prevents steatosis in Otsuka Long-Evans Tokushima fatty rats","volume":"294","author":"Rector","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.metabol.2019.05.009_bb0180","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2337\/dc11-0925","article-title":"Independent and combined effects of exercise training and metformin on insulin sensitivity in individuals with prediabetes","volume":"35","author":"Malin","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2019.05.009_bb0185","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1172\/JCI70704","article-title":"Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production","volume":"124","author":"Merovci","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2019.05.009_bb0190","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1210\/jc.2018-01741","article-title":"Influence of sodium glucose co-transporter 2 inhibition on the physiological adaptation to endurance exercise training","volume":"104","author":"Newman","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2019.05.009_bb0195","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1249\/MSS.0000000000000223","article-title":"Impact of various exercise modalities on hepatic mitochondrial function","volume":"46","author":"Fletcher","year":"2014","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.metabol.2019.05.009_bb0200","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/35093131","article-title":"CREB regulates hepatic gluconeogenesis through the coactivator PGC-1","volume":"413","author":"Herzig","year":"2001","journal-title":"Nature."},{"key":"10.1016\/j.metabol.2019.05.009_bb0205","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.2337\/db07-1087","article-title":"Pck1 gene silencing in the liver improves glycemia control, insulin sensitivity, and dyslipidemia in db\/db mice","volume":"57","author":"Gomez-Valades","year":"2008","journal-title":"Diabetes."},{"key":"10.1016\/j.metabol.2019.05.009_bb0210","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.2337\/diabetes.51.7.2179","article-title":"Glycemic control determines hepatic and peripheral glucose effectiveness in type 2 diabetic subjects","volume":"51","author":"Hawkins","year":"2002","journal-title":"Diabetes."},{"key":"10.1016\/j.metabol.2019.05.009_bb0215","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/dom.13224","article-title":"Intra- and inter-subject variability for increases in serum ketone bodies in patients with type 2 diabetes treated with the sodium glucose co-transporter 2 inhibitor canagliflozin","volume":"20","author":"Polidori","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.metabol.2019.05.009_bb0220","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1113\/JP275709","article-title":"Prior ingestion of exogenous ketone monoester attenuates the glycaemic response to an oral glucose tolerance test in healthy young individuals","volume":"596","author":"Myette-Cote","year":"2018","journal-title":"J Physiol"},{"key":"10.1016\/j.metabol.2019.05.009_bb0225","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1139\/cjpp-2018-0359","article-title":"Empagliflozin improves cardiorespiratory fitness in type 2 diabetes: translational implications","volume":"96","author":"Kumar","year":"2018","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.metabol.2019.05.009_bb0230","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1113\/expphysiol.2012.069633","article-title":"Elevated energy coupling and aerobic capacity improves exercise performance in endurance-trained elderly subjects","volume":"98","author":"Conley","year":"2013","journal-title":"Exp Physiol"},{"key":"10.1016\/j.metabol.2019.05.009_bb0235","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1152\/japplphysiol.90384.2008","article-title":"Separate and combined effects of exercise training and weight loss on exercise efficiency and substrate oxidation","volume":"105","author":"Amati","year":"2008","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.metabol.2019.05.009_bb0240","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S1262-3636(07)70315-4","article-title":"Substrate oxidation during exercise: type 2 diabetes is associated with a decrease in lipid oxidation and an earlier shift towards carbohydrate utilization","volume":"32","author":"Ghanassia","year":"2006","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.metabol.2019.05.009_bb0245","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.cmet.2016.07.010","article-title":"Nutritional ketosis alters fuel preference and thereby endurance performance in athletes","volume":"24","author":"Cox","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2019.05.009_bb0250","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1139\/apnm-2016-0641","article-title":"Nutritional ketone salts increase fat oxidation but impair high-intensity exercise performance in healthy adult males","volume":"42","author":"O'Malley","year":"2017","journal-title":"Appl Physiol Nutr Metab"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049519300976?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049519300976?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:20:37Z","timestamp":1758428437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049519300976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":50,"alternative-id":["S0026049519300976"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2019.05.009","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The combination of exercise training and sodium-glucose cotransporter-2 inhibition improves glucose tolerance and exercise capacity in a rodent model of type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2019.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}